drugset / Trial / NCT03756389
Evaluation of Topical Application of BMX-010 in Subjects With Rosacea
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This is an exploratory Phase 2 trial of BMX-010 in patients with Rosacea which will be conducted in two parts. Up to 210 subjects with Rosacea will be enrolled.
Timeline
- Start
- 2018-01-03
- Primary completion
- 2024-09
- Completion
- 2025-03
Outcome
Outcome not reported
Stopped: “Re-formulation of study product”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BMX-010 | Unknown | 0.03 % | Topical |
| Subject | BMX-010 | Unknown | 0.1 % | Topical |